Claudia Angela Maria Fulgenzi

6PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 10, 2025
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer.

David J Pinato, Pasquale Lombardi, Antonio D'Alessio

|Apr 05, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.

David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi

|Oct 28, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.

Khalil Choucair, Caroline Nebhan, Alessio Cortellini

|Oct 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.

Vincent Joerg, Bernhard Scheiner, Antonio D Alessio

|Jan 11, 2022
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.

Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri

|Sep 03, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer.

Michela Roberto, Giulia Arrivi, Francesca Lo Bianco

Pageof 1

Frequent Collaborators

4 joint publications

Antonio D'Alessio

4 joint publications

David J Pinato

3 joint publications

Alessio Cortellini

2 joint publications

Bernhard Scheiner